288 results on '"Djaldetti, R"'
Search Results
2. Predictors and Pathophysiology of Axial Postural Abnormalities in Parkinsonism: A Scoping Review.
3. Task Force Consensus on Nosology and Cut-Off Values for Axial Postural Abnormalities in Parkinsonism
4. Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinsonʼs disease
5. Current management of motor fluctuations in patients with advanced Parkinson’s disease treated chronically with levodopa
6. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for Huntington's disease
7. Whole genome analysis in a consanguineous family with early onset Alzheimer's disease
8. High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease
9. Accordion pill carbidopa/levodopa (AP-CD/LD) for treatment of advanced PD: 668
10. The association between response to pain stimulation and genetic variance for pain in patients with Parkinsonʼs disease: 666
11. Decreased dopamine transporter binding ipsilateral to the clinically more affected side in Parkinsonʼs disease: Which side to take?: 618
12. Clinical characteristics of long-term survivors in multiple system atrophy: An analysis of the EMSA-SG registry: 299
13. Do melanocortin-1-receptor (MC1R) gene variants predispose for both Parkinsonʼs disease and malignant melanoma?: 135
14. Clinical characteristics of Parkinson’s disease among Jewish Ethnic groups in Israel
15. [123I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor
16. High glucosylceramides and low anandamide contribute to sensory loss and pain in Parkinson's disease
17. Primary postural instability: a cause of recurrent sudden falls in the elderly
18. Skin biopsy for assessment of autonomic denervation in Parkinson’s disease
19. The European Multiple System Atrophy-Study Group (EMSA-SG)
20. Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease
21. The effect of deprenyl washout in patients with long-standing Parkinson's disease
22. Contribution of genetic variants to pain susceptibility in Parkinson disease
23. Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers
24. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment
25. Camptocormia in Parkinson’s disease: new insights
26. Early-occurrence of manual motor blocks in Parkinson's disease: a quantitative assessment
27. Consensus for the measurement of the camptocormia angle in the standing patient
28. Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study
29. Abnormal skin wrinkling in the less affected side in hemiparkinsonism – a possible test for sympathetic dysfunction in Parkinson’s disease
30. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
31. IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease
32. Decreased phagocytic function in patients with Parkinson's disease
33. Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
34. Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation
35. Red flags for multiple system atrophy
36. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)
37. Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease
38. Presentation, diagnosis, and management of multiple system atrophy in Europe:final analysis of the European multiple system atrophy registry
39. ON BEHALF OF THE EMSA‐SG. PRESENTATION, DIAGNOSIS, AND MANAGEMENT OF MULTIPLE SYSTEM ATROPHY IN EUROPE: FINAL ANALYSIS OF THE EUROPEAN MULTIPLE SYSTEM ATROPHY REGISTRY
40. The natural history of multiple system atrophy: a prospective European cohort study
41. Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study)
42. A double-blind, delayed-start trial of rasagiline in Parkinson's disease
43. Cannabis Smoking for Treatment of Parkinson's Disease (PD4.005)
44. The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
45. 123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Recurrent Sudden Falls: Are Such Falls a Distinct Entity?
46. Quantitative measurement of pain sensation in patients with Parkinson disease
47. Familial infantile bilateral striatal necrosis
48. Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa
49. Enhanced fatigue during motor performance in patients with Parkinson's disease
50. Management of response fluctuations: Practical guidelines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.